Geographic miss of lung tumours due to respiratory motion: a comparison of 3D vs 4D PET/CT defined target volumes

BackgroundPET/CT scans acquired in the radiotherapy treatment position are typically performed without compensating for respiratory motion. The purpose of this study was to investigate geographic miss of lung tumours due to respiratory motion for target volumes defined on a standard 3D-PET/CT.Methods29 patients staged for pulmonary malignancy who completed both a 3D-PET/CT and 4D-PET/CT were included. A 3D-Gross Tumour Volume (GTV) was defined on the standard whole body PET/CT scan. Subsequently a 4D-GTV was defined on a 4D-PET/CT MIP. A 5 mm, 10 mm, 15 mm symmetrical and 15×10 mm asymmetrical Planning Target Volume (PTV) was created by expanding the 3D-GTV and 4D-GTV’s. A 3D conformal plan was generated and calculated to cover the 3D-PTV. The 3D plan was transferred to the 4D-PTV and analysed for geographic miss. Three types of miss were measured. Type 1: any part of the 4D-GTV outside the 3D-PTV. Type 2: any part of the 4D-PTV outside the 3D-PTV. Type 3: any part of the 4D-PTV receiving less than 95% of the prescribed dose. The lesion motion was measured to look at the association between lesion motion and geographic miss.ResultsWhen a standard 15 mm or asymmetrical PTV margin was used there were 1/29 (3%) Type 1 misses. This increased 7/29 (24%) for the 10 mm margin and 23/29 (79%) for a 5 mm margin. All patients for all margins had a Type 2 geographic miss. There was a Type 3 miss in 25 out of 29 cases in the 5, 10, and 15 mm PTV margin groups. The asymmetrical margin had one additional Type 3 miss. Pearson analysis showed a correlation (p < 0.01) between lesion motion and the severity of the different types of geographic miss.ConclusionWithout any form of motion suppression, the current standard of a 3D- PET/CT and 15 mm PTV margin employed for lung lesions has an increasing risk of significant geographic miss when tumour motion increases. Use of smaller asymmetric margins in the cranio-caudal direction does not comprise tumour coverage. Reducing PTV margins for volumes defined on 3D-PET/CT will greatly increase the chance and severity of a geometric miss due to respiratory motion. 4D-imaging reduces the risk of geographic miss across the population of tumour sizes and magnitude of motion investigated in the study.

[1]  R Laforest,et al.  Generating lung tumor internal target volumes from 4D-PET maximum intensity projections. , 2011, Medical physics.

[2]  M. Schneider-Kolsky,et al.  Geographic miss in radiation oncology: Have we missed the boat? , 2009, Journal of medical imaging and radiation oncology.

[3]  Annette Kopp-Schneider,et al.  4D-CT-based target volume definition in stereotactic radiotherapy of lung tumours: comparison with a conventional technique using individual margins. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  L. Dunn,et al.  Motion effects on SUV and lesion volume in 3D and 4D PET scanning , 2011, Australasian Physical & Engineering Sciences in Medicine.

[5]  Alessandra Zorz,et al.  Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  Ross Berbeco,et al.  Evaluation of the combined effects of target size, respiratory motion and background activity on 3D and 4D PET/CT images , 2008, Physics in medicine and biology.

[7]  Tomas Kron,et al.  Validation of a 4D-PET maximum intensity projection for delineation of an internal target volume. , 2013, International journal of radiation oncology, biology, physics.

[8]  Rodney J Hicks,et al.  Reproducibility of "intelligent" contouring of gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method. , 2007, International journal of radiation oncology, biology, physics.

[9]  E. Yorke,et al.  (18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[10]  Tomio Inoue,et al.  Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  S. Senan,et al.  Defining target volumes for stereotactic ablative radiotherapy of early-stage lung tumours: a comparison of three-dimensional 18F-fluorodeoxyglucose positron emission tomography and four-dimensional computed tomography. , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

[12]  W. Stanford,et al.  Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography. , 1990, International journal of radiation oncology, biology, physics.

[13]  M. V. van Herk,et al.  Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[14]  D. Yan,et al.  Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.

[15]  Li Zhang,et al.  Assessment of Respiration-Induced Motion and Its Impact on Treatment Outcome for Lung Cancer , 2013, BioMed research international.

[16]  K. Camphausen,et al.  Advances in 4D Medical Imaging and 4D Radiation Therapy , 2008, Technology in cancer research & treatment.

[17]  Tonghai Liu,et al.  Comparison of the planning target volume based on three-dimensional CT and four-dimensional CT images of non-small-cell lung cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  C. Ling,et al.  Effect of respiratory gating on quantifying PET images of lung cancer. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  Giuseppe Lucio Cascini,et al.  Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC). , 2007, Lung cancer.

[20]  L. Court,et al.  Using four‐dimensional computed tomography images to optimize the internal target volume when using volume‐modulated arc therapy to treat moving targets , 2012, Journal of applied clinical medical physics.

[21]  R. Hicks,et al.  Role of PET-CT in the Optimization of Thoracic Radiotherapy , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[22]  Brian O'Sullivan,et al.  Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Steve B. Jiang,et al.  The management of respiratory motion in radiation oncology report of AAPM Task Group 76. , 2006, Medical physics.

[24]  4D PET-CT guided radiation therapy. , 2013, JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie.